时间控制适应性通气对急性呼吸窘迫综合征病因的生物学反应差异
该研究为动物实验,42只Wistar大鼠分别经气管内或腹腔注射大肠埃希菌脂多糖诱导肺源性和肺外源性急性呼吸窘迫综合征,24小时后随机接受1小时容量控制通气或时间控制适应性通气(潮气量8 mL/kg)。时间控制适应性通气设定为持续气道正压高于基线呼吸系统峰值压力2 cm H2O,Thigh 0.75-0.85秒,释放压力0 cm H2O,Tlow 0.11-0.18秒,目标呼气末流速与峰值呼气流速比75%。结果显示时间控制适应性通气在两种病因中均增加呼吸系统平均压力;在肺源性急性呼吸窘迫综合征中,时间控制适应性通气较容量控制通气降低弥漫性肺泡损伤评分,并减少双调蛋白、血管细胞黏附分子-1和金属蛋白酶-9表达;在肺外源性急性呼吸窘迫综合征中,时间控制适应性通气较未通气组降低弥漫性肺泡损伤评分。作者结论认为,在肺源性急性呼吸窘迫综合征中,时间控制适应性通气对过度膨胀和细胞外基质稳态相关生物标志物表达产生更明显的有益效应。
要点
- 在肺源性急性呼吸窘迫综合征大鼠中,时间控制适应性通气较容量控制通气降低弥漫性肺泡损伤评分。
- 在肺源性急性呼吸窘迫综合征中,容量控制通气而非时间控制适应性通气增加双调蛋白、血管细胞黏附分子-1和金属蛋白酶-9表达。
- 在肺外源性急性呼吸窘迫综合征中,时间控制适应性通气较未通气组降低弥漫性肺泡损伤评分。
- 时间控制适应性通气在两种病因中均增加呼吸系统平均压力。
- 无论急性呼吸窘迫综合征病因,时间控制适应性通气较未通气组胶原密度更高、核心蛋白聚糖表达更低。
适用人群与场景
- Wistar大鼠,经气管内滴注大肠埃希菌脂多糖诱导肺源性急性呼吸窘迫综合征或经腹腔注射诱导肺外源性急性呼吸窘迫综合征,24小时后进行通气实验。
处置流程与药物剂量
- 时间控制适应性通气(气道压力释放通气模式):持续气道正压设为高于基线呼吸系统峰值压力2 cm H2O,Thigh 0.75-0.85秒;释放压力0 cm H2O,Tlow 0.11-0.18秒,目标呼气末流速与峰值呼气流速比75%;潮气量8 mL/kg。
- 容量控制通气:潮气量8 mL/kg,通气1小时。
研究设计与关键结果
- 动物实验,42只Wistar大鼠,随机分为容量控制通气组(每种病因n=7)、时间控制适应性通气组(每种病因n=7)和未通气组(每种病因n=7)。
- 时间控制适应性通气在两种病因中均增加呼吸系统平均压力。
- 肺源性急性呼吸窘迫综合征中,时间控制适应性通气组弥漫性肺泡损伤评分低于容量控制通气组;肺外源性急性呼吸窘迫综合征中,时间控制适应性通气组弥漫性肺泡损伤评分低于未通气组。
- 肺源性急性呼吸窘迫综合征中,容量控制通气而非时间控制适应性通气增加双调蛋白、血管细胞黏附分子-1和金属蛋白酶-9表达。
- 无论病因,时间控制适应性通气组较未通气组胶原密度更高、核心蛋白聚糖表达更低。
- 肺源性急性呼吸窘迫综合征中,时间控制适应性通气增加多配体蛋白聚糖表达,肺外源性急性呼吸窘迫综合征中未增加。
证据类型、等级与局限
- 证据类型:动物实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在肺源性急性呼吸窘迫综合征中,时间控制适应性通气对过度膨胀和细胞外基质稳态相关生物标志物表达产生更明显的有益效应。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare a time-controlled adaptive ventilation strategy, set in airway pressure release ventilation mode, versus a protective mechanical ventilation strategy in pulmonary and extrapulmonary acute respiratory distress syndrome with similar mechanical impairment.
DESIGN: Animal study.
SETTING: Laboratory investigation.
SUBJECTS: Forty-two Wistar rats.
INTERVENTIONS: Pulmonary acute respiratory distress syndrome and extrapulmonary acute respiratory distress syndrome were induced by instillation of Escherichia coli lipopolysaccharide intratracheally or intraperitoneally, respectively. After 24 hours, animals were randomly assigned to receive 1 hour of volume-controlled ventilation (n = 7/etiology) or time-controlled adaptive ventilation (n = 7/etiology) (tidal volume = 8 mL/kg). Time-controlled adaptive ventilation consisted of the application of continuous positive airway pressure 2 cm H2O higher than baseline respiratory system peak pressure for a time (Thigh) of 0.75-0.85 seconds. The release pressure (Plow = 0 cm H2O) was applied for a time (Tlow) of 0.11-0.18 seconds. Tlow was set to target an end-expiratory flow to peak expiratory flow ratio of 75%. Nonventilated animals (n = 7/etiology) were used for Diffuse Alveolar Damage and molecular biology markers analyses.
MEASUREMENT AND MAIN RESULTS: Time-controlled adaptive ventilation increased mean respiratory system pressure regardless of acute respiratory distress syndrome etiology. The Diffuse Alveolar Damage score was lower in time-controlled adaptive ventilation compared with volume-controlled ventilation in pulmonary acute respiratory distress syndrome and lower in time-controlled adaptive ventilation than nonventilated in extrapulmonary acute respiratory distress syndrome. In pulmonary acute respiratory distress syndrome, volume-controlled ventilation, but not time-controlled adaptive ventilation, increased the expression of amphiregulin, vascular cell adhesion molecule-1, and metalloproteinase-9. Collagen density was higher, whereas expression of decorin was lower in time-controlled adaptive ventilation than nonventilated, independent of acute respiratory distress syndrome etiology. In pulmonary acute respiratory distress syndrome, but not in extrapulmonary acute respiratory distress syndrome, time-controlled adaptive ventilation increased syndecan expression.
CONCLUSION: In pulmonary acute respiratory distress syndrome, time-controlled adaptive ventilation led to more pronounced beneficial effects on expression of biomarkers related to overdistension and extracellular matrix homeostasis.
参考来源
- Silva PL, Cruz FF, Samary CDS, et al. Biological Response to Time-Controlled Adaptive Ventilation Depends on Acute Respiratory Distress Syndrome Etiology. Crit Care Med. 2018. PMID: 29485489. doi:10.1097/CCM.0000000000003078
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。